Fig. 3From: Selective antagonism of cJun for cancer therapySchematic of cJun binding interfaces and molecules that target them. The cJun-DNA interaction can be antagonised by binding to the TRE site on DNA (MLN44 [129], SR11302 [135]), the cJun DBD (T-5224)Â [51], the cJun LZ (anti-Jun and anti-Fos SZ [144], FosUisCan [125]) or the full cJun bZIP domain (A-Fos [148])Back to article page